Cancel

Analyst coverage & consensus

Check the latest analyst estimates by VARA Research

Disclaimer

Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Analyst coverage

A wide range of sell-side analysts provide coverage of dsm-firmenich for their clients and the broader market.

Sell-side analyst coverage
InstitutionAnalyst
ABN AMROUsama Tariq
Baader BankTheodore Duval-Segard  
Bank of America Merrill LynchMatthew Yates
BarclaysAlex Sloane
Berenberg BankSebastian Bray
BernsteinVictoria Nice
CitigroupSebastian Satz
Davy ResearchCathal Kenny
Deutsche BankVirginie Boucher-Ferte
EquitaMassimo Bonisoli
Exane BNP ParibasNicola Tang
Goldman SachsGeorgina Fraser
INGReg Watson
JefferiesMarcus Dunford-Castro
JP MorganChetan Udeshi
KBC SecuritiesWim Hoste
Kepler ChevreuxMartin Rödiger
Morgan StanleyLisa De Neve
DeGroof PetercamFernand de Boer
Rothschild & Co RedburnArtem Chubarov
UBSChristian Bell
Van Lanschot Kempen Eric Wilmer
VontobelArben Hasanaj
Zürcher KantonalbankDaniel Bürki

Disclaimer
Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Consensus figures as per 7 September 2026

The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.

 Q3 2025 ActualFY 2025 ActualQ1 2026 ActualQ2 2026 ActualH1 2026 ActualQ3 2026EFY 2026EFY 2027E
 Continuing Operations Only
dsm-firmenich, total sales (€ m)2,2389,0342,2762,3884,6642,3559,2819,719
         
P&B9373,7609679811,9489873,8724,066
TTH7873,1467918431,6348273,2263,393
HNC5072,1024975381,0355222,1012,198
Corporate726212647198479
         
dsm-firmenich, total organic sales growth in %2346.05.04.74.94.6
         
P&B3387.07.05.56.15.0
TTH3426.04.04.64.35.1
HNC0344.04.04.74.44.5
         
dsm-firmenich, total Adj. EBITDA margin %20.519.619.119.519.320.319.620.2
         
P&B22.021.722.021.521.822.121.622.1
TTH21.020.619.120.219.620.920.220.8
HNC21.719.419.320.419.921.520.420.8
         
dsm-firmenich, total Adj. EBITDA (€ m)4581,7724344669004781,8181,961
P&B206815213211424218837899
TTH165648151170321173653707
HNC11040796110206112428458
Corporate-23-98-26-25-51-24-99-98
         
Adj. EBIT (€ m)-861--435-8981,034
         
Core adj. EBIT (€ m)-1,290--664-1,2821,432
         
Core adj. net profit (€ m)-887--465-9101,017
         
Core adj. EPS (€)-3.31--1.84-3.654.12
         
Adjusted Gross Operating Free Cash Flow (€ m) -950--320-1,0641,385
         
Adjusted Gross Operating Free Cash Flow/Sales %-10.5--7.0-11.514.2
         
Net debt IFRS (€ m)-3,301--4,424-3,4823,283

Disclaimer
Any opinions, forecasts, estimates, projections, or predictions regarding dsm-firmenich’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of dsm-firmenich or its management. By providing the names of the analysts, dsm-firmenich does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. dsm-firmenich assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Contact Investor Relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

Get in touch
Explore more

  • Results center

    All the key financial performance information published dsm-firmenich

    Read more

  • Financial results & presentations

    All the key financial performance information published dsm-firmenich

    Read more

  • Financial calendar

    A handy overview of the key dates in our financial calendar.

    Read more

Stay up to date

Be the first to know about key news as we continue shaping the future and bringing progress to life.

Subscribe to our newsletter